A new study has found that patients taking metformin, a common diabetes drug, tend to have significantly lower blood levels of copper and iron, with raised levels of zinc. These changes may be linked ...

A Kobe University study found that type 2 diabetes patients taking metformin had lower blood copper and iron levels but higher zinc. These shifts support the idea that metformin’s ability to bind ...

Metformin, a commonly prescribed anti-diabetic drug, could impact metal levels in blood by significantly lowering copper and iron and spiking zinc amounts, possibly related to preventing complications ...

Metformin hydrochloride is type of medicine called a biguanide. Metformin is used when diet alone has failed to fully control blood sugar. It may be used on its own, in combination with other oral ...

Scientists found that metformin acts in the brain through Rap1 to control blood sugar. This insight could lead to more precise diabetes treatments. Metformin has been the standard treatment for type 2 ...

The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action.

Prediabetes is a common and rising global health concern, impacting a large and growing share of the population, The virtual ...

Objective Delayed-release metformin (Met DR) is formulated to deliver the drug to the lower bowel to leverage the gut-based mechanisms of metformin action with lower plasma exposure. Met DR was ...

Moving to mice studies, the researchers homed in on exactly how this microbial metabolite could be inhibiting the action of metformin.